Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.
about
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational researchAlphavirus-based vaccinesImmunotherapy for cervical cancer: Research status and clinical potentialSunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication.Therapeutic Vaccine Strategies against Human Papillomavirus.Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7.A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development.Targeted treatments for cervical cancer: a review.Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions.Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis.Immunologic treatments for precancerous lesions and uterine cervical cancer.Oncolytic Alphaviruses in Cancer Immunotherapy.Noninvasive monitoring of cancer therapy induced activated T cells using [18F]FB-IL-2 PET imaging.CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.Therapeutic vaccines for high-risk HPV-associated diseases.Targeting Head and Neck Cancer by Vaccination.Therapeutic human papillomavirus vaccines: current clinical trials and future directionsEmerging human papillomavirus vaccinesPotent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigensThe Journey of Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
P2860
Q26744094-1D025F30-DF53-4E68-8303-23C023A3D644Q26994724-EDD006DE-49A6-432A-BC33-5BC841E7DAEAQ34033763-E18C0446-C3A5-4582-B7F9-CC471554716FQ35506659-598286D3-E63A-4ECC-8460-60D79D9D12D2Q35826752-569798F1-D629-4367-82BB-21A4A5795090Q35826994-8DD44AB9-6BD9-4252-AD38-98176C1F4A55Q36107975-3ACFA178-8B64-4695-A851-CB5B0D654137Q36384032-EA89D2CA-7B95-45A3-B77D-4DDB8678BF1AQ36987072-8EBBC60F-3CEA-493D-9C79-7E2F1087814AQ37135023-AA3F60A1-82AD-4A24-B4CB-59776305A3EEQ37579334-EF8B2312-726E-4A41-B143-186B88ED25EBQ37703113-5C0FEEE0-15CE-43DC-9E27-9A86B0E9F6F9Q39247874-77D065C6-BF44-4854-B0E2-FD681BE47512Q40336066-974DD057-F7B0-40BB-8269-AE9A15DD983CQ41067857-007976D1-2050-49FC-8781-E2B09AD94CABQ47255618-7771A917-8780-4A22-8169-2B90332D2ED5Q54217605-EA07633E-08AC-4CB8-B982-E7430AA2D2A3Q56937332-B3B89353-16E8-4300-A880-989B033DD4CBQ56967486-EC6141C0-353B-43A5-8C26-F8B458BE62F7Q57138571-8684AF8B-CC64-4910-9CA8-C223408A2C48Q58750585-4B2605F8-EBF2-4747-9A69-A338DCD78377
P2860
Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Superior therapeutic efficacy ...... of the route of immunization.
@en
type
label
Superior therapeutic efficacy ...... of the route of immunization.
@en
prefLabel
Superior therapeutic efficacy ...... of the route of immunization.
@en
P2093
P1433
P1476
Superior therapeutic efficacy ...... s of the route of immunization
@en
P2093
Annelies Riezebos-Brilman
Ate van der Zee
Bert Dontje
Joke Regts
P304
P577
2004-10-01T00:00:00Z